Breast cancer symptoms can be similar to those of less common medical conditions, but they are important to recognise and to get checked out by your GP as it affects one in eight women at some point in their life.
The most common symptom of breast cancer is a lump. But it should be noted that the majority of breast lumps are benign and not cancerous.
Evgen Pharma (LON:EVG) is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.